Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 198,766 | 189,247 | 316,773 | 264,541 | 294,374 |
| Marketable Securities | 153,616 | 152,670 | 67,162 | N/A | N/A |
| Receivables | 20,000 | N/A | N/A | N/A | N/A |
| TOTAL | $379,779 | $349,717 | $391,302 | $271,150 | $299,707 |
| Non-Current Assets | |||||
| PPE Net | 4,682 | 5,044 | 5,538 | 6,006 | 6,314 |
| Investments And Advances | 10,556 | 18,114 | 0 | 0 | 0 |
| Other Non-Current Assets | 24,693 | 24,252 | 25,218 | 26,363 | 26,819 |
| TOTAL | $39,931 | $47,410 | $30,756 | $32,369 | $33,133 |
| Total Assets | $419,710 | $397,127 | $422,058 | $303,519 | $332,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,013 | 1,794 | 2,918 | 3,666 | 2,404 |
| Accrued Expenses | 12,385 | 15,967 | 14,430 | 11,516 | 11,539 |
| TOTAL | $21,236 | $22,556 | $22,112 | $19,900 | $18,617 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,833 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 17,940 | 19,605 | 20,510 | 21,381 | 22,155 |
| TOTAL | $56,773 | $19,605 | $20,510 | $21,381 | $22,155 |
| Total Liabilities | $78,009 | $42,161 | $42,622 | $41,281 | $40,772 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,345 | 49,709 | 48,119 | 43,851 | 43,797 |
| Common Shares | 50 | 49 | 48 | 44 | 44 |
| Retained earnings | -513,755 | -489,547 | -454,979 | -424,892 | -391,213 |
| Other shareholders' equity | -135 | 110 | 69 | 0 | 0 |
| TOTAL | $341,701 | $354,966 | $379,436 | $262,238 | $292,068 |
| Total Liabilities And Equity | $419,710 | $397,127 | $422,058 | $303,519 | $332,840 |